Citations for
1NRXN2, NRXN3
Neurexin gene family variants as risk factors for autism spectrum disorder.
Wang J, Gong J, Li L, Chen Y, Liu L, Gu H, Luo X, Hou F, Zhang J, Song R.
Autism Res. Jan;11(1):37-43. doi: 10.1002/aur.1881. Epub 2017 Oct 16. 2018
2NRXN2, NRXN3
Neurexins 1-3 Each Have a Distinct Pattern of Expression in the Early Developing Human Cerebral Cortex
Harkin LF, Lindsay SJ, Xu Y, Alzu'bi A, Ferrara A, Gullon EA, James OG, Clowry GJ.
Cereb Cortex. Jan 1;27(1):216-232. doi: 10.1093/cercor/bhw394. Erratum in: Cereb Cortex. 2019 Apr 1;29(4):1705. 2017
3NRXN1, NRXN2, NRXN3
Exonal Elements and Factors Involved in the Depolarization-Induced Alternative Splicing of Neurexin 2.
Rozic G, Lupowitz Z, Zisapel N.
J Mol Neurosci Mol Neurosci. 2012 Nov 21. [Epub ahead of print] 2012
4NRXN1, NRXN2
Truncating mutations in NRXN2 and NRXN1 in autism spectrum disorders and schizophrenia.
Gauthier J, Siddiqui TJ, Huashan P, Yokomaku D, Hamdan FF, Champagne N, Lapointe M, Spiegelman D, Noreau A, Lafrenière RG, Fathalli F, Joober R, Krebs MO, DeLisi LE, Mottron L, Fombonne E, Michaud JL, Drapeau P, Carbonetto S, Craig AM, Rouleau GA.
Hum Genet 130(4):563-73. doi: 10.1007/s00439-011-0975-z. Epub 2011 Mar 22. 2011
5NRXN1, NRXN2, NRXN3
Regulation of neurexin 1beta tertiary structure and ligand binding through alternative splicing.
Shen KC, Kuczynska DA, Wu IJ, Murray BH, Sheckler LR, Rudenko G.
Structure 16(3):422-31.PMID: 18334217 2008
6NRXN2
Ca2+ -dependent splicing of neurexin IIalpha.
Rozic-Kotliroff G, Zisapel N.
Biochem Biophys Res Commun 352(1):226-30. Epub 2006 Nov 10. 2007
7NRXN1, NRXN2, NRXN3
Analysis of the human neurexin genes: alternative splicing and the generation of protein diversity.
Rowen L, Young J, Birditt B, Kaur A, Madan A, Philipps DL, Qin S, Minx P, Wilson RK, Hood L, Graveley BR.
Genomics 79(4):587-97. 2002
8CAPN1, MEN1, MAP4K2, VEGFB, NRXN2
A 500-kb sequence-ready cosmid contig and transcript map of the MEN1 region on 11q13.
Bergman L, Silins G, Grimmond S, Hummerich H, Stewart C, Little P, Hayward N.
Genomics 55(1):49-56. 1999
9AKAP2, AMOTL2, ANKRD6, ARSG, ASXL1, ATG4B, BAHD1, BIRC6, BTBD3, C6orf84, CAMK2A, CAMKK2, CARD8, CHSY1, CORO2A, CPEB3, DIP2C, DLGAP4, DNAJC16, DNAJC9, DZIP1, EFR3B, EXOC6B, FAIM2, FASTKD2, FNBP4, INPP5F, LRCH1, NLGN4Y, NLRP1, NRXN2, PADI2, PCNX, PDS5B, PLEKHA6, PSD3, R3HDM2, RPH3A, SBNO2, SEZ6L, STK38L, TBC1D30, THOC5, TLL2, USP20, ZBTB1, ZFP30
Prediction of the coding sequences of unidentified human genes. XIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.
Nagase T, Ishikawa K, Suyama M, Kikuno R, Hirosawa M, Miyajima N, Tanaka A,Kotani H, Nomura N, Ohara O.
DNA Res 6(1):63-70. 1999
10NRXN1, NRXN2, NRXN3, CNTNAP1
Neurexins : three genes and 1001 products.
Missler M, Sudhof TC.
Trends Genet 14(1):20-6. 1998
11EHD1, ZFPL1, MEN1, NRXN2, SNX9, SNX15, DPF2
A transcript map for the 2.8-Mb region containing the multiple endocrine neoplasia type 1 locus.
Guru SC, Agarwal SK, Manickam P, Olufemi SE, Crabtree JS, Weisemann JM, Kester MB, Kim YS, Wang Y, Emmert-Buck MR, Liotta LA, Spiegel AM, Boguski MS, Roe BA, Collins FS, Marx SJ, Burns L, Chandrasekharappa SC.
Genome Res 7(7):725-35. 1997